JBJS reprinted data from the Fracture Reduction Evaluation (FREE) study. With 300 patients enrolled at 21 Eu sites were suffering from acute VCFs, which is relevant as the age of the fracture has been considered a factor contributing to mixed results for VCF treatments noted in other studies. FREE was not blinded. There were two serious adverse events in the kyphoplasty group, which did not differ significantly from the group treated non-surgically.
HealthPointCapital... http://ow.ly/FKlv
...
The Orthopedics Industry 
